Shares of Health Care sector company Globus Medical moved 1.4% today, and are now trading at a price of $87.24. The Large-Cap stock's daily volume was 150,477 compared to its average volume of 1,592,918. The S&P 500 index returned a 1.0% performance.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company is based in Audubon and has 5,300 full time employees. Its market capitalization is $11,782,393,856.
10 analysts are following Globus Medical and have set target prices ranging from $70.0 to $114.0 per share. On average, they have given the company a rating of buy. At today's prices, GMED is trading -4.34% away from its average analyst target price of $91.2 per share.
Over the last year, GMED's share price has increased by 1.8%, which represents a difference of -8.5% when compared to the S&P 500. The stock's 52 week high is $94.93 per share whereas its 52 week low is $51.79. With average free cash flows of $188.43 Million that have been growing at an average rate of 27.9% over the last 5 years, Globus Medical is in a position to continue its strong stock performance trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 520,638 | 115,429 | 405,209 | 145.25 |
| 2023 | 243,499 | 78,274 | 165,225 | 58.23 |
| 2022 | 178,468 | 74,047 | 104,421 | -52.4 |
| 2021 | 276,274 | 56,898 | 219,376 | 62.34 |
| 2020 | 198,793 | 63,658 | 135,135 | 33.5 |
| 2019 | 171,975 | 70,750 | 101,225 |
